Back to 
Quadrature Capital Ltd
Quadrature Capital Ltd
LTRN
1 quarters
Position history for Quadrature Capital Ltd's holdings in Lantern Pharma Inc.
Yes. Quadrature Capital holds 39,593 shares of LTRN (Lantern Pharma), worth $165,103, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$165,103
Current Shares
39,593
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of LTRN: NewEdge Advisors, LLC, Vanguard Capital Management LLC, Vanguard Group Inc.